A Wisconsin family is suing Walgreens and OptumRx after a sudden inhaler price hike from $66 to $539 forced their son to ...
Cencora Enjoys Growth Momentum From GLP-1s, Healthy Utilization Trends, and Growing Specialty Assets
Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...
After Groundhog Day and Valentine's Day pass next month, certain Floridians will celebrate Presidents Day. Here's what will ...
We recently compiled a list of the Jim Cramer Recently Talked About These 11 S&P 500 Stocks. In this article, we are going to ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a ...
The retail space in Roxbury that had been vacated by Walgreens for more than a year has a new tenant: Vicente’s Supermarket, ...
The company said that it now owns a 6% stake in Cencora, trimming it down from 10% it previously held. It sold Cencora shares worth $1.1 billion in August. Walgreens has sold about $265 million worth ...
An Amber Alert has been issued for a pregnant Wisconsin teen, who police believe is with the 40-year-old man who impregnated ...
Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier ...
Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” fourth-quarter 2024 investor ...
Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a deal to rescue the drugstore empire he built is proving difficult.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results